NASDAQ:MNTL Tema Neuroscience and Mental Health ETF (MNTL) Price, Holdings, & News $25.51 +0.37 (+1.47%) (As of 12/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsShort InterestTrends About Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MNTL alerts:Sign Up Key Stats Today's Range$25.51▼$25.5150-Day Range$24.67▼$27.5352-Week Range$23.67▼$27.66Volume9 shsAverage Volume12,321 shsMarket Capitalization$11.22 millionAssets Under Management$11.20 millionDividend Yield0.98%Net Expense Ratio0.75%Aggregate RatingN/A ETF OverviewThe Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema.Read More… Tema Neuroscience and Mental Health ETF ExpensesTypeMNTLTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.99%0.57%0.55%0.50%0.52%Other Expenses0.00%0.57%0.49%0.41%0.53%Total Expense0.99%0.72%0.71%0.64%0.71%Fee Waiver-0.24%-0.73%-0.51%-0.31%-0.56%Net Expense0.75%0.60%0.61%0.57%0.59% Receive MNTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address MNTL ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MNTL ETF - Frequently Asked Questions How have MNTL shares performed this year? Tema Neuroscience and Mental Health ETF's stock was trading at $25.49 on January 1st, 2024. Since then, MNTL shares have increased by 0.1% and is now trading at $25.5053. View the best growth stocks for 2024 here. How do I buy shares of Tema Neuroscience and Mental Health ETF? Shares of MNTL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details IssuerTema Global Fund NameTema Neuroscience and Mental Health ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:MNTL Inception Date1/22/2024 Fund ManagerDavid Song, Yuri Khodjamirian WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings49 Fund Statistics Assets Under Management$11.05 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorUS Bancorp Fund Services, LLC AdvisorTema Global Limited CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentUS Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest1,100 shs Miscellaneous Outstanding Shares440,000Beta0.99 Creation Unit10,000 Creation Fee$500.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report MNTL Sector ExposureMNTL Industry Exposure This page (NASDAQ:MNTL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
